{
  "docId": "019de076-5923-773b-8485-b914b8e85d5b",
  "docSlug": "aa767e092bc23262b7b522a6b0c001e5",
  "documentTitle": "MindMed | Results Presentation Deck | 20 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 20,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-5923-773b-8485-b914b8e85d5b/4",
  "deckHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b",
  "deckJsonHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b.json",
  "deckAnchorHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.08,
        "x": 0.19,
        "y": 0.00124
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f7d16f8-db36-48a1-91d7-dce2db4a5e72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.24,
        "w": 0.7,
        "x": 0.15,
        "y": 0.00124
      },
      "kind": "list",
      "text": "A Diversified pipeline of clinical programs targeting significant unmet medical needs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69e3e825-483b-41d2-8902-2979fdfe72bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.24,
        "w": 0.7,
        "x": 0.15,
        "y": 0.39
      },
      "kind": "list",
      "text": "Advanced clinical development of product candidates: MM-120: Phase 2b – dose-optimization (GAD), MM-120: Phase 2a – proof-of-concept (ADHD), MM-402: IND-enabling, MM-402: Phase 1 IIT – R-, S- and R/S-MDMA",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e0a2092-3a71-4497-849f-c3006c07bc91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.24,
        "w": 0.7,
        "x": 0.15,
        "y": 0.71
      },
      "kind": "list",
      "text": "Expected cash runway through key clinical readouts and into 2026*",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef97100f-f439-48a6-a955-a80bca7b5fe8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.66,
        "x": 0.168,
        "y": 0.935
      },
      "kind": "source-note",
      "text": "*The company's ending Q3 2023 cash and cash equivalents of $117.7 million and committed credit facility are expected to fund operations into 2026, if certain milestones are achieved that unlock additional capital.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24e29bea-4147-488a-9b9f-eee8f6367a29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.092,
        "w": 0.648,
        "x": 0.038,
        "y": 0.048
      },
      "kind": "title",
      "text": "We Aim To Be A Global Leader In Brain Health",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1a3713de-8beb-4a8d-9843-b696564e189d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "578bb249-ccab-4e4f-b26d-8c87f598b99c",
      "evidence": "Advanced clinical development of product candidates: MM-120: Phase 2b – dose-optimization (GAD), MM-120: Phase 2a – proof-of-concept (ADHD), MM-402: IND-enabling, MM-402: Phase 1 IIT – R-, S- and R/S-MDMA",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 1,
      "beatId": "df068b9b-cca6-4bd1-9d7f-c38bf9153a78",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "The cover, disclaimer, team bio, and key takeaways slides provide an introduction to the presentation.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "b638ff59-97f7-4353-9280-5fdfd3586639",
      "evidence": "The key takeaways and key messages slides provide an overview of MindMed's goals and strengths.",
      "position": 1,
      "objective": "Why is MindMed well-positioned to address brain health disorders?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}